Jean Chidiac

Colombes, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Prognosis of Recurrent Venous Thromboembolism During Extended Apixaban Therapy for Cancer-Associated Thrombosis: Insights From the API-CAT Randomized Trial.

Prognosis of Recurrent Venous Thromboembolism During Extended Apixaban Therapy for Cancer-Associated Thrombosis: Insights From the API-CAT Randomized Trial.

Journal: Circulation

Published: July 13, 2026

Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.

Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.

Journal: The New England journal of medicine

Published: March 31, 2025

Cancer-associated thrombosis: what is new?

Cancer-associated thrombosis: what is new?

Journal: Current opinion in oncology

Published: January 27, 2025

Diagnostic Approach for Venous Thromboembolism in Cancer Patients.

Diagnostic Approach for Venous Thromboembolism in Cancer Patients.

Journal: Cancers

Published: April 29, 2023

Granulosa tumor: two spontaneous pregnancies after combined medico-surgical treatment: case report and review of the literature.

Granulosa tumor: two spontaneous pregnancies after combined medico-surgical treatment: case report and review of the literature.

Journal: Journal of medical case reports

Published: September 21, 2022

Long-Term Treatment of Cancer-Associated Thrombosis (CAT) Beyond 6 Months in the Medical Practice: USCAT, a 432-Patient Retrospective Non-Interventional Study.

Long-Term Treatment of Cancer-Associated Thrombosis (CAT) Beyond 6 Months in the Medical Practice: USCAT, a 432-Patient Retrospective Non-Interventional Study.

Journal: Cancers

Published: July 03, 2020

Patients experience of living with cancer associated thrombosis in France (Le PELICAN).

Patients experience of living with cancer associated thrombosis in France (Le PELICAN).

Journal: Thrombosis research

Published: April 15, 2020

Cancer and venous thromboembolism recurrence: The keys for an optimal management

Cancer and venous thromboembolism recurrence: The keys for an optimal management

Journal: Bulletin du cancer

Published: June 27, 2017

PO-23 - Expression of heparanase in cancer as biomarker of malignancies: overexpression in an aggressive, poor survival gastric cancer "gastric signet ring cell carcinoma" compared with that of other gastric cancers.

PO-23 - Expression of heparanase in cancer as biomarker of malignancies: overexpression in an aggressive, poor survival gastric cancer "gastric signet ring cell carcinoma" compared with that of other gastric cancers.

Journal: Thrombosis research

Published: May 11, 2016

PO-47 - Microparticles derived from ovarian cancer cell line contained genomic and biologically active proteins, including tissue factor involved in coagulation.

PO-47 - Microparticles derived from ovarian cancer cell line contained genomic and biologically active proteins, including tissue factor involved in coagulation.

Journal: Thrombosis research

Published: May 11, 2016

Factors influencing adherence to clinical guidelines in the management of cancer-associated thrombosis.

Factors influencing adherence to clinical guidelines in the management of cancer-associated thrombosis.

Journal: Journal of thrombosis and haemostasis : JTH

Published: January 26, 2016

The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site.

The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site.

Journal: The American journal of medicine

Published: January 26, 2016

Showing 1-12 of 18

Last Updated: 09/26/2026